Friedreich’s ataxia (FA) is a progressive genetic disorder of the nervous system that is characterized by incoordination and cardiac degeneration. It results from the expression of a non-functional frataxin protein, which normally helps to maintain appropriate iron levels within mitochondria. The mutant protein causes cytosolic iron deficiency and mitochondrial iron overloading by methods that are not understood. Huang et al. used a conditional knockout mouse model, where frataxin was specifically deleted in only the heart and skeletal muscle, to investigate the role of frataxin in iron localization and metabolism in these tissues. Without frataxin, the expression of the iron import protein transferrin receptor 1 (TfR1) increases along with heme catabolism by heme oxygenase 1. Iron storage in cytosolic ferritin decreases and the accumulating free iron is transported into mitochondria through the transport protein mitoferrin 2 (Mfrn2), which is also upregulated in the absence of frataxin. This demonstrates a possible mechanism for the mitochondrial iron loading that underlies the pathology of Friedreich’s ataxia.
Neurodegeneration: ironing out the mechanism of Friedreich’s ataxia
Neurodegeneration: ironing out the mechanism of Friedreich’s ataxia. Dis Model Mech 5 November 2009; 2 (11-12): 518. doi:
Download citation file:
Advertisement
Cited by
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modelling
The ISSCR provides comprehensive guidelines and standards for using human stem cells in biomedical research. In this Editorial, Cody Juguilon and Joseph Wu discuss how and why these should be incorporated in disease modelling research.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
Other journals from
The Company of Biologists